Sanjiv Jindia, MD
Anesthesiology · Lafayette, LANPI 1316934466
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 26.6% of the total. Reporting peaked in 2019 at $287 and has fallen 69.9% since, to $87 in 2025.
Across 28 payments — averaging $29.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$217
- Abbott$200
- Medtronic$161
- Boston Scientific$42
- Nevro Corp.$34
- Acacia Pharma Inc$30
- plus $132 from 7 others
What the payments were for
- Food & beverage$816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 2 | $217 |
| Abbott | 2 | $200 |
| Medtronic(2 entities) | 11 | $161 |
| Boston Scientific | 2 | $42 |
| Nevro Corp. | 2 | $34 |
| Acacia Pharma Inc | 2 | $30 |
| Avanos Medical | 1 | $29 |
| Saluda Medical Americas, Inc. | 1 | $25 |
| Spinal Simplicity, LLC | 1 | $18 |
| Stryker | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Valinor Pharma, LLC | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$816 in reported general payments places this provider in the 85th percentile of 497 anesthesiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,273 | $25,834 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 522 | $14,053 |
| LinzessLinaclotide | 19 | $9,573 |
| Xtampza ErOxycodone Myristate | 12 | $8,022 |
| Gabapentin | 815 | $7,704 |
| Oxycodone Hcl | 385 | $7,645 |
| Hydrocortisone Butyrate | 12 | $6,983 |
| MovantikNaloxegol Oxalate | 15 | $5,762 |
| Morphine Sulfate ErMorphine Sulfate | 196 | $4,817 |
| Baclofen | 528 | $4,703 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 30 | $4,424 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 64 | $4,268 |
| Fentanyl | 42 | $3,304 |
| Betamethasone Dipropionate | 22 | $2,749 |
| Pregabalin | 285 | $2,440 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Lafayette
- Matthew MitchellLafayette$5K
- Danielle BabbLafayette$3K
- Amarendar KasarlaLafayette$2K
- William DedoLafayette$2K
- Keith MayfieldShreveport$32K
- John GuilliotNew Orleans$32K
- Brian CrenshawBenton$26K
- Caroline CarrollShreveport$26K
- Aya MouhaffelShreveport$20K
- Richard FairShreveport$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.